Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Bronchial hyperreactivity and nCPAP therapy]

G Wenzel1, B Schönhofer, M Wenzel

  • 1Krankenhaus Kloster Grafschaft, Zentrum für Pneumologie und Allergologie, Schmallenberg-Grafschaft.

Pneumologie (Stuttgart, Germany)
|August 1, 1997
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Prediction of abdominal CT body composition parameters by thoracic measurements as a new approach to detect sarcopenia in a COVID-19 cohort.

Scientific reports·2022
Same author

[Early Pulmonary Rehabilitation after Long Term Mechanical Ventilation].

Pneumologie (Stuttgart, Germany)·2021
Same author

[Limits and Ethics of Mechanical Ventilation and Intensive Care Medicine in Old Age].

Pneumologie (Stuttgart, Germany)·2021
Same author

[Acute Necrotizing Pneumonia in Blue Tits - Implications for Pulmonology in Dialogue with Veterinary Medicine].

Pneumologie (Stuttgart, Germany)·2021
Same author

Pneumologie (Stuttgart, Germany)·2021
Same author

[Weaning in a Pandemic Situation - A Position Paper].

Pneumologie (Stuttgart, Germany)·2020
Same journal

Pneumologie (Stuttgart, Germany)·2026
Same journal

Aerosol therapy during noninvasive ventilation (NIV) and nasal high-flow therapy (HFT): current technology and consensus-based recommendations.

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Correction: Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Erratum: Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Pharmacotherapy for Tobacco Dependence: Implementation of the Current G-BA Resolution - Information from Section E3 of the DGP regarding the G-BA Resolution].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[Acute lung failure].

Pneumologie (Stuttgart, Germany)·2026
Same journal

[The internet as a source of information for patients with sarcoidosis].

Pneumologie (Stuttgart, Germany)·2026
See all related articles

Continuous positive airway pressure (CPAP) therapy for obstructive sleep apnoea (OSA) rarely induces significant bronchial hyperreactivity (BHR). For most patients, CPAP benefits outweigh potential airway irritation risks.

Area of Science:

  • Respiratory Medicine
  • Sleep Medicine
  • Pulmonology

Context:

  • Obstructive sleep apnoea (OSA) is often treated with nasal continuous positive airway pressure (nCPAP).
  • nCPAP may cause upper airway mucosal irritation.
  • The potential for nCPAP to induce bronchial hyperreactivity (BHR) requires investigation.

Purpose:

  • To determine if nCPAP therapy for OSA can induce bronchial hyperreactivity (BHR).

Summary:

  • Forty-one OSA patients underwent BHR testing before and after six weeks of nCPAP therapy.
  • Most patients (35/41) did not develop BHR.
  • Six patients developed moderate BHR; two reported mild symptoms, and none discontinued therapy due to BHR.
  • Four patients had pre-existing BHR.

Related Experiment Videos

Impact:

  • nCPAP therapy for OSA is generally safe regarding BHR induction.
  • While BHR can develop, it often lacks clinical significance.
  • The therapeutic benefits of nCPAP in OSA patients with BHR typically exceed potential adverse effects.